Barclays PLC Biote Corp. Call Options Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BTMD
# of Institutions
83Shares Held
17.7MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$30.7 Million13.05% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$16.5 Million5.13% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$9.58 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.39MShares$9.42 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $51.2M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...